In this episode, Geoffrey Dusheiko, FRCP, FRCP (Edin), FCP (SA), and Ming-Lung Yu, MD, PhD, discuss key racial inequities of care that lead to undertreatment for migrant populations and other racial minorities globally with or at risk for hepatitis B. In addition, they discuss plans to improve engagement across the care continuum and strategies to combat implicit racial biases that affect optimal HBV care.Topics include:Differences in the burden of HBV globallySuboptimal engagement of HBV careStigma associated with HBV careKey strategies for overcoming racial barriersFirst-hand patient storiesGeoffrey Dusheiko, FRCP, FRCP (Edin), FCP (SA)Emeritus Professor of MedicineConsultant HepatologistUniversity College London Medical SchoolProfessorLiver UnitKings College HospitalLondon, United KingdomMing-Lung Yu, MD, PhDChair ProfessorHepatobiliary DivisionDepartment of Internal Medicine and Hepatitis CenterKaohsiung Medical UniversityVisiting StaffHepatobiliary DivisionDepartment of Internal MedicineKaohsiung Medical University HospitalKaohsiung City, TaiwanKaohsiung City, Taiwan Content based on a CME program supported by educational grants provided by AbbVie; Gilead Sciences, Inc.; and Janssen Therapeutics, Division of Janssen Products, LP To follow along, download the slides at:https://bit.ly/3gWStjZLink to full program: https://bit.ly/3kKIb9a Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related